State-of-the-art strategies for targeting the DNA damage response in cancer
Year: 2018
Type: review
Source: Nature Reviews Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: DNA damage response, cancer therapy, PARP inhibitors, synthetic lethality, BRCA mutations, ATM inhibitors, ATR inhibitors, CHK1 inhibitor, CHK2 inhibitors, DNA-PK inhibitor, WEE1 inhibitor, genomic instability, predictive biomarkers, drug resistance, combination therapy, DNA repair deficiency, clonal evolution
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2898088739
